• Busca personas
• Intranet

Neurología de Sistemas y Neuroterapias Pablo Villoslada Díaz

Publicaciones 2024 (25)

• Carbayo Á, Borrego Écija S, Turon-Sans J, Cortés-Vicente E, Molina-Porcel L, Gascón-Bayarri J, Rubio MA, Povedano M, Gámez J, Sotoca J, Juntas-Morales R, Almendrote M, Marquié M, Sánchez Valle R, Illán Gala I, Dols Icardo O, Rubio-Guerra S, Bernal S, Caballero-Ávila M, Vesperinas A, Gelpi E^*, Rojas-García R^*. Clinicopathological correlates in frontotemporal lobar degeneration: motor neuron disease spectrum. Brain 2024: (en Premsa).
• Macias A, Jiménez J^*, Fernández-Pérez I, Suarez A, Vallverdú-Prats M, Guimaraens L, Vivas E, Saldaña J, Giralt E, Guisado D, Villalba G, Gracia-Arnillas MP, Esteller M, Rodríguez Campello A, Jiménez Conde J, Ois A, Cuadrado E. The influence of epigenetic biological age on key complications and outcomes in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2024: (en Premsa).
• Fernández-Pérez I, Jiménez J^*, Macias A, Suarez A, Vallverdú-Prats M, Perez-Giraldo A, Viles-Garcia M, Peris-Subiza J, Vidal-Notari S, Giralt E, Guisado D, Esteller M, Rodríguez Campello A, Jiménez Conde J, Ois A, Cuadrado E. Blood DNA Methylation Analysis Reveals a Distinctive Epigenetic Signature of Vasospasm in Aneurysmal Subarachnoid Hemorrhage. Transl Stroke Res . 2024: (en Premsa).
• Fernández-Hernández R^*, Martínez-Rodríguez JE, Saint-Gerons M, Tariq Bhatti M. Not everything is ischemic optic neuropathy. Surv Ophthalmol 2024: (en Premsa).
• Boccuni L, Roca-Ventura A, Buloz-Osorio EA, Leno-Colorado D, Delgado-Gallén S, Cabello-Toscano M, Perellón-Alfonso R, Villalba G, Martínez-Ricarte F, Martin-Fernandez J, Buxeda-Rodriguez M, Conesa G, Illueca-Moreno M, Lladó E, Perla y Perla C, Garrido C , Pariente JC, Laredo C, Muñoz-Moreno E, Bargalló N, Trompetto C, Marinelli L, Bartrés-Faz D, Abellaneda-Pérez K^*, Pascual-Leone Á^*, Tormos-Muñoz M^*. Non-invasive prehabilitation to foster widespread fMRI cortical reorganization before brain tumor surgery: lessons from a case series. J Neuro-Oncol 2024: (en Premsa).
• Mosteiro A, Llull L, Pedrosa L, Amaro S, Reyes L, Basco J, Zattera L, De Riva N, Arikan F, Gandara D, Villalba G, Cuadrado E, Rodríguez-Hernández A, Blanco A, Muñoz F, Rico M, Romero-Chala F, Alvarez P, López-Ojeda P, Chirife O, Salvat M, Ros J, Pérez de la Ossa N, Torné R^*. The HSACAT Project: A Prospective Multicentre Observational Study of Spontaneous Subarachnoid Haemorrhage in Catalonia (Spain). World Neurosurg 2024: (en Premsa).
• Villoslada P, Solana E, Alba-Arbalat S, Martinez-Heras E, Vivo F, Lopez-Soley E, Calvi A, Camos-Carreras A, Dotti-Boada M, Alcubierre R, Martinez-Lapiscina EH, Blanco Y, Llufriu S, Sanchez-Dalmau B^*. Retinal Damage and Visual Network Reconfiguration Defines Visual Function Recovery in Optic Neuritis. Neurol Neuroimmunol Neuroinflamm 2024; 11(6): e200288.
• Abellaneda-Pérez K, Delgado I, Salgado P, Gines JM, Guardiola R, Vaqué-Alcazar L, Roca-Ventura A, Molist-Puigdomènech R, Manero RM, Viles-Garcia M, Medrano-Martorell S, Bartrés-Faz D, Pascual-Leone Á, Pérez V, Villalba G^*. Structural connectivity modifications following deep brain stimulation of the subcallosal cingulate and nucleus accumbens in severe anorexia nervosa. Acta Neurochir 2024; 166(1): 364.
• Gonzalez-Ortiz F^*, Kirsebom BE, Contador J, Tanley JE, Selnes P, Gísladóttir B, Pålhaugen L, Suhr-Hemminghyt M, Jarholm J, Skogseth R, Bråthen G, Grøndtvedt G, Bjørnerud A, Tecelao S, Waterloo K, Aarsland D, Fernández A, García-Escobar G, Navalpotro I, Turton M, Hesthamar A, Kac PR, Nilsson J, Luchsinger J, Hayden KM, Harrison P, Puig-Pijoan A, Zetterberg H, Hughes TM, Suarez-Calvet M, Karikari TK, Fladby T, Blennow K. Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease. Nat Commun 2024; 15(1): 2908.
• Falcon C, Montesinos P, Václavu L, Kassinopoulos M, Minguillón C, Fauria K, Cascales D, Contador J, Fernández A, Navalpotro I, Puig-Pijoan A, Grau-Rivera O, Kollmorgen G, Quijano-Rubio C, Molinuevo JL, Zetterberg H, Blennow K, Suarez-Calvet M, Van Osch MJP, Sanchez-Gonzalez J, Gispert JD^*. Time-encoded ASL reveals lower cerebral blood flow in the early AD continuum. Alzheimers Dement 2024; 20(8): 5183-5197.
• Bansal P, Banda EC, Glatt-deeley HR, Stoddard CE, Linsley JW, Arora N, Deleschaux C, Ahern DT, Kondaveeti Y, Massey RE, Nicouleau M, Wang S, Sabariego-Navarro M, Dierssen M, Finkbeiner S, Pinter SF^*. A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction. Sci Adv 2024; 10(23): eadj0385.
• Boccuni L, Roca-Ventura A, Buloz-Osorio EA, Leno-Colorado D, Martin-Fernandez J, Cabello-Toscano M, Perellón-Alfonso R, Pariente-Zorrilla JC, Laredo C, Garrido C , Muñoz-Moreno E, Bargalló N, Villalba G, Martínez-Ricarte F, Trompetto C, Marinelli L, Sacchet MD, Bartrés-Faz D, Abellaneda-Pérez K^*, Pascual-Leone Á, Tormos-Muñoz M^*. Exploring the neural basis of non-invasive prehabilitation in brain tumour patients: An fMRI-based case report of language network plasticity. Front Oncol 2024; 14: 1390542 (Acceptat).
• Cámara A^*, Compta Y, Baixauli M, Maragall L, Pérez-Soriano A, Montagut N, Ahuir M, Ludeña E, Peri L, Fernández N, Villote S, Lopez-de los Reyes JC, Navarro-Otano J, Zaro I, Muñoz E, Buongiorno M, Caballol N, Pont-Sunyer C, Puente VM, Giraldo D, Valldeoriola F, Lombraña M, Martí MJ. Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study. Parkinsonism Relat Disord 2024; 124: 106993.
• Soldevila N, Fagundo B, Cuenca A, Forcano L, Gomis-González M, Boronat A, Pastor A, Castañer O, Zomeño MD, Goday A, Dierssen M, Baghizadeh K, Ros E, Corella D, Martínez-González MA, Salas Salvadó J, Fernández-Aranda F, Fitó Colomer M, de la Torre R^*. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention. Nutr J 2024; 23(1): 61.
• Salari M, Etemadifar M, Zali A, Aminzade Z, Navalpotro I, Tehrani-Fateh S^*. Covid-19 in Parkinson's Disease treated by drugs or brain stimulation. Neurología (Barc) 2024; 39(3): 254-260.
• Baune BT^*, Minelli A, Carpiniello B, Contu M, Domínguez J, Donlo MJ, Ferensztajn-Rochowiak E, Glaser R, Kelch B, Kobelska P, Kolasa G, Kopec D, Martínez de Lagrán M, Martini P, Mayer MA, Menesello V, Paribello P, Perera J, Perusi G, Pinna F, Pinna M, Pisanu C, Sierra C, Stonner I, Wahner VTH, Xicota L, Zang JCS, Gennarelli M, Manchia M, Squassina A, Potier MC, Rybakowski F, Sanz F, Dierssen M. An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response. Front Psychiatry 2024; 14: 1279688 (Acceptat).
• Alba-Arbalat S, Solana E, Lopez-Soley E, Camos-Carreras A, Martínez-Heras E, Vivó F, Pulido-Valdeolivas I, Andorra M, Sepulveda M, Cabrera JM, Fonseca E, Calvi A, Alcubierre R, Dotti-Boada M, Saiz A, Martínez-Lapiscina EH, Villoslada P, Blanco Y, Sanchez-Dalmau B, Llufriu S^*. Predictive value of retinal atrophy for cognitive decline across disease duration in multiple sclerosis. J Neurol Neurosurg Psychiatry 2024; 95(5): 419-425.
• Andorra M, Freire A, Zubizarreta I, Kerlero N, Bos SD, Rinas M, Høgestøl EA, de Rodez SA, Berge T, Brune-Ingebretse S, Ivaldi F, Cellerino M, Pardini M, Vila G, Pulido-Valdeolivas I, Martinez-Lapiscina EH, Llufriu S, Saiz A, Blanco Y, Martinez-Heras E, Solana E, Bäcker-Koduah P, Behrens J, Kuchling J, Asseyer S, Scheel M, Chien C, Zimmermann H, Motamedi S, Kauer-Bonin J, Brandt A, Saez-Rodriguez J, Alexopoulos LG, Paul F, Harbo HF, Shams H, Oksenberg J, Uccelli A, Baeza-Yates R, Villoslada P^*. Predicting disease severity in multiple sclerosis using multimodal data and machine learning. J Neurol 2024; 271(3): 1133-1149.
• Jiang Y, Uhm H, Ip FC, Ouyang L, Lo RMN, Cheng EYL, Cao X, Tan CMC, Law BCH, Ortiz-Romero P, Puig-Pijoan A, Fernández A, Contador J, Mok KY, Hardy J, Kwok TCY, Mok VCT, Suarez-Calvet M, Zetterberg H, Fu AKY, Ip NY^*. A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups. Alzheimers Dement 2024; 20(3): 2000-2015.
• Fernández-Blanco Á, Sierra C, Tejido C, Dierssen M^*. Beyond Quiescent and Active: Intermediate Microglial Transcriptomic States in a Mouse Model of Down Syndrome. Int J Mol Sci 2024; 25(6): 3289.
• Bertran-Recasens B, Balañá A, Martínez-Llorens JM, Guillén A, Villatoro M, García-Escobar G, Umayahara Y, Soh Z, Tsuji T, Rubio MA^*. Sound-based cough peak flow estimation in patients with neuromuscular disorders. Muscle Nerve 2024; 69(2): 213-217.
• Kennedy KE, Abenza JF, Rossetti L, Trepat X, Villoslada P, Garcia-Ojalvo J^*. Parametric modeling of mechanical effects on circadian oscillators. Chaos 2024; 34(1): 013135.
• García-Escobar G, Manero RM, Fernández A, Ois A^*, Navalpotro I, Puente VM, Contador J, Estragues Gazquez I, Puig-Pijoan A, Jiménez J. Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review. Biomolecules 2024; 14(1): 93.
• Martínez de Lagrán M, Bascón-Cardozo K, Dierssen M^*. Neurodevelopmental disorders: 2024 update. Free Neuropathol . 2024; 5: 5-20 (Acceptat).
• Puig-Pijoan A^*, Jiménez J^*, Fernández A, García-Escobar G, Navalpotro I, Contador J, Manero RM, Puente VM, Suarez A, Muñoz-López FJ, Grau-Rivera O, Suarez-Calvet M, de la Torre R, Roquer-González J, Ois A^*. Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: A longitudinal study in a memory unit clinical cohort. Alzheimers Dement 2024; 20(1): 538-548.